GE HealthCare: Jefferies upgrades stock

(CercleFinance.com) - Jefferies announced on Wednesday that it had upgraded its recommendation on GE Healthcare shares from "hold" to "buy", also increasing its target price for them from $95 to $103.


The broker sees an attractive entry point for the stock, which is currently trading at just 17x-18x earnings, below the valuation of its closest comparables and its recent highs of around 20x.

Even in the absence of an upturn in business in China, the analyst believes the stock has upside potential, thanks to the strength of its pharmaceutical diagnostics business (PDx) and its market share gains, both of which could be boosted by the pleasant surprise of a Chinese recovery.

Jefferies has added the stock to its list of preferred stocks ('franchise pick').


Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.